Biogen Inc’s recent filing unveils that its Head of Development Singhal Priya unloaded Company’s shares for reported $88019.0 on Sep 03 ’24. In the deal valued at $204.22 per share,431 shares were sold. As a result of this transaction, Singhal Priya now holds 5,316 shares worth roughly $0.84 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Singhal Priya bought 431 shares, generating $88,019 in total proceeds.
Before that, Singhal Priya sold 93 shares. Biogen Inc shares valued at $19,817 were divested by the Head of Development at a price of $213.09 per share. As a result of the transaction, Singhal Priya now holds 4,886 shares, worth roughly $0.77 million.
Needham downgraded its Biogen Inc [BIIB] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”a Peer perform”‘ rating. Citigroup began covering BIIB with “Neutral” recommendation on November 14, 2024. Morgan Stanley revised its rating on October 31, 2024. It rated BIIB as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of BIIB
On Tuesday, Biogen Inc [NASDAQ:BIIB] saw its stock fall -0.64% to $157.69. Over the last five days, the stock has gained 1.45%. Biogen Inc shares have fallen nearly -39.06% since the year began. Nevertheless, the stocks have fallen -31.08% over the past one year. While a 52-week high of $268.30 was reached on 01/03/24, a 52-week low of $153.62 was recorded on 11/20/24. SMA at 50 days reached $180.21, while 200 days put it at $206.96.
Levels Of Support And Resistance For BIIB Stock
The 24-hour chart illustrates a support level at 155.85, which if violated will result in even more drops to 154.02. On the upside, there is a resistance level at 159.76. A further resistance level may holdings at 161.84. The Relative Strength Index (RSI) on the 14-day chart is 25.68, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.73, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.55%. Stochastics %K at 18.03% indicates the stock is a buying.
How much short interest is there in Biogen Inc?
A steep rise in short interest was recorded in Biogen Inc stocks on 2024-11-15, dropping by -0.37 million shares to a total of 2.7 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 3.07 million shares. There was a decline of -13.8%, which implies that there is a negative sentiment for the stock.
